GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation

Gene

Volumn 512, Issue 2, 2013, Pages 198-205

  Bu, Xianmin ^a   Zhao, Chenghai ^a   Wang, Wei ^a   Zhang, Ning ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Gastric cancer cell; GRIM 19; Radiation; STAT3

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; STAT3 PROTEIN;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GRIM 19 GENE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CANCER; TREATMENT RESPONSE;

AGED; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NADH, NADPH OXIDOREDUCTASES; NEOPLASM PROTEINS; RADIATION TOLERANCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; X-RAYS;

EID: 84870341215     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.057     Document Type: Article

References (18)

1. Alchanati I., et al. A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 2006, 25:7138-7147.
2. Angell J.E., Lindner D.J., Shapiro P.S., Hofmann E.R., Kalvakolanu D.V. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J. Biol. Chem. 2000, 275:33416-33426.
3. Berman D.M., et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003, 425:846-851.
4. Bromberg J.F., et al. Stat3 as an oncogene. Cell 1999, 98:295-303.
5. Hofmann E.R., et al. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol. Cell. Biol. 1998, 18:6493-6504.
6. Kalakonda S., et al. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels. Am. J. Pathol. 2007, 171:1352-1368.
7. Kalakonda S., Nallar S.C., Lindner D.J., Hu J., Reddy S.P., Kalvakolanu D.V. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3. Cancer Res. 2007, 67:6212-6220.
8. Kiesslich T., Alinger B., Wolkersdörfer G.W., Ocker M., Neureiter D., Berr F. Active Wnt signalling is associated with low differentiation and high proliferation in human biliary tract cancer in vitro and in vivo and is sensitive to pharmacological inhibition. Int. J. Oncol. 2010, 36:49-58.
9. Krysko D.V., Vanden Berghe T., D'Herde K., Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods 2008, 44:205-221.
10. Lindner D.J., Borden E.C., Kalvakolanu D.V. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo. Clin. Cancer Res. 1997, 3:931-937.
11. Lotan R., Dawson M.I., Zou C.C., Jong L., Lotan D., Zou C.P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 1994, 55:232-236.
12. Lufei C., et al. GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction. EMBO J. 2003, 22:1325-1335.
13. Mairs R.J., Fullerton N.E., Zalutsky M.R., Boyd M. Targeted radiotherapy: microgray doses and the bystander effect. Dose-Response 2007, 5:204-213.
14. Moore D.M., et al. Retinoic acid and interferon in human cancer: mechanistic and clinical studies. Semin. Hematol. 1994, 31:31-37.
15. Prise K.M., O'Sullivan J.M. Radiation-induced bystander signaling in cancer therapy. Nat. Rev. Cancer 2009, 9:351-360.
16. Reits E.A., et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J. Exp. Med. 2006, 203:1259-1271.
17. Seo T., et al. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated Herpes virus interacts with a cell death regulator, GRIM19, and inhibits interferon/retinoic acid-induced cell death. J. Virol. 2002, 76:8797-8807.
18. Zhang J., et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9342-93427.